FDA Approves First Drug for Advanced Macular Degeneration

Teprotumumab reduces inflammation, which causes damage in the eye that leads to progressive central vision loss.

Goggles
Getty Images

Macular degeneration is caused by the deterioration of the macula, a small part of the retina that is responsible for sharp, central vision. It’s most common in older adults and can lead to severe vision loss or blindness. According to a recent CBS News article, the FDA has approved the first and only drug for the treatment of advanced macular degeneration. The drug, teprotumumab, is administered intravenously and has proven effective in clinical trials, with some patients experiencing significant improvement in vision.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report